trimethoprim has been researched along with Prostatic Neoplasms in 1 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lopes, DL | 1 |
| Araújo, Sde A | 1 |
| Santos, JP | 1 |
| Lyon, AC | 1 |
| Dantas, DV | 1 |
| Reis, BS | 1 |
| de Góes, AM | 1 |
| Pedroso, ER | 1 |
1 other study available for trimethoprim and Prostatic Neoplasms
| Article | Year |
|---|---|
Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer.
Topics: Antiprotozoal Agents; Diagnosis, Differential; Humans; Itraconazole; Male; Middle Aged; Paracoccidio | 2009 |